CYBERDYNE (7779) AI Stock Analysis

• Market Cap: ¥40.01B
• Dividend Yield: N/A
• Average Volume (3M): 724.97K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.76
• Revenue Growth: -4.30%
• EPS Growth: 82.87%
• Country: JP
• Employees: 227
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): -0.86
• Shares Outstanding: 137,445,820
• 10 Day Avg. Volume: 764,380
• 30 Day Avg. Volume: 724,970
• PEG Ratio: 1.05
• Price to Book (P/B): 0.93
• Price to Sales (P/S): 8.43
• P/FCF Ratio: -50.27
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 55 Neutral
• Price Target: ¥195.00 ▲(4.84% Upside)

The overall stock score is primarily influenced by significant financial challenges, particularly in profitability and cash flow management. Technical analysis provides some positive momentum, but poor valuation metrics weigh heavily on the score. The absence of earnings call and corporate events data limits further insights.

Positive Factors

Strategic Partnerships

These partnerships expand market reach and promote technology adoption, strengthening CYBERDYNE's position in the healthcare sector.

Product Diversification

Diversification into multiple sectors reduces dependency on a single market, enhancing resilience against sector-specific downturns.

Low Leverage

Minimal leverage reduces financial risk and enhances the company's ability to invest in growth opportunities without significant debt burden.

Negative Factors

Profitability Challenges

Persistent profitability issues can hinder reinvestment in R&D and limit competitive positioning in the long term.

Revenue Decline

Significant revenue decline suggests challenges in market demand or competitive pressures, impacting future growth prospects.

Cash Flow Management

Weak cash flow management can lead to liquidity issues, limiting the company's ability to fund operations and strategic initiatives.

CYBERDYNE Business Overview & Revenue Model

Company Description

CYBERDYNE (7779) is a Japanese robotics and technology company specializing in the development of advanced robotic systems designed to assist and enhance human capabilities. The company operates primarily in the healthcare and industrial sectors, focusing on products such as the HAL (Hybrid Assistive Limb) exoskeleton, which is used for rehabilitation and assistance for individuals with mobility impairments. CYBERDYNE also engages in research and development of robotics technologies for various applications, including disaster response and industrial automation.

How the Company Makes Money

CYBERDYNE generates revenue through multiple channels, including the sale of its robotic products such as the HAL exoskeleton, which is marketed to hospitals and rehabilitation centers. The company also earns income from leasing its robotic systems and providing maintenance and support services. Additionally, CYBERDYNE has formed strategic partnerships with healthcare providers and research institutions, which help to expand its market reach and promote the adoption of its technologies. Grants and funding for research projects further contribute to its revenue streams, particularly in the development of new applications and enhancements of existing products.

CYBERDYNE Financial Statement Overview

Summary

CYBERDYNE faces financial challenges with declining revenues and profitability issues, as reflected in negative margins and cash flows. The balance sheet remains a strength with low leverage, but the company needs to address operational inefficiencies and improve cash flow generation to enhance financial health.

Income Statement

CYBERDYNE's income statement shows a declining revenue trend with a negative revenue growth rate of -3.54% in the TTM. The company has a gross profit margin of 54.13%, which is relatively strong, but the net profit margin is negative at -13.14%, indicating losses. The EBIT and EBITDA margins are also negative, reflecting operational challenges.

Balance Sheet

The balance sheet is relatively stable with a low debt-to-equity ratio of 0.011, suggesting low leverage. However, the return on equity is negative at -1.43%, indicating inefficiencies in generating returns from equity. The equity ratio is strong, showing a solid capital structure.

Cash Flow

CYBERDYNE's cash flow statement reveals negative operating and free cash flows, with a significant decline in free cash flow growth at -59.64% in the TTM. The operating cash flow to net income ratio is negative, indicating cash flow challenges. However, the free cash flow to net income ratio is positive, suggesting some ability to cover net losses.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	4.20B	4.38B	4.35B	3.29B	2.15B	1.88B
Gross Profit	2.22B	2.37B	2.39B	1.79B	1.28B	1.30B
EBITDA	766.00M	16.00M	-2.00M	873.00M	116.00M	892.00M
Net Income	-201.00M	-577.00M	-1.48B	-298.00M	-498.00M	-59.00M
Balance Sheet
Total Assets	48.91B	48.55B	50.00B	50.19B	48.12B	47.81B
Cash, Cash Equivalents and Short-Term Investments	15.08B	14.86B	16.66B	17.31B	5.68B	6.70B
Total Debt	442.00M	434.00M	632.00M	669.00M	575.00M	421.00M
Total Liabilities	9.30B	8.95B	9.52B	8.20B	4.33B	3.55B
Stockholders Equity	39.60B	39.58B	40.75B	42.10B	43.41B	43.78B
Cash Flow
Free Cash Flow	-118.00M	-735.00M	-1.07B	-652.00M	-1.85B	-620.00M
Operating Cash Flow	4.00M	-430.00M	-850.00M	-143.00M	-775.00M	-215.00M
Investing Cash Flow	322.00M	2.33B	-2.08B	2.17B	-2.79B	-244.00M
Financing Cash Flow	-218.00M	-216.00M	160.00M	14.00M	617.00M	1.30B

CYBERDYNE Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 186.00
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7779, the sentiment is Neutral. The current price of 186 is above the 20-day moving average (MA) of 181.50, above the 50-day MA of 182.04, and above the 200-day MA of 181.56, indicating a bullish trend. The MACD of 3.22 indicates Negative momentum. The RSI at 49.94 is Neutral, neither overbought nor oversold. The STOCH value of 22.45 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:7779.

CYBERDYNE Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6678	74 Outperform	¥18.93B	15.61	―	3.02%	-4.36%	-14.92%
6823	69 Neutral	¥31.75B	10.19	―	2.99%	6.72%	20.01%
4549	66 Neutral	¥81.99B	21.24	―	2.25%	4.36%	79.43%
7600	58 Neutral	¥12.61B	-14.29	―	3.13%	3.59%	-163.08%
7779	55 Neutral	¥40.01B	-192.31	-0.46%	―	-4.30%	82.87%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
7777	50 Neutral	¥41.35B	-354.67	1.45%	―	40.50%	91.59%

CYBERDYNE Corporate Events

CYBERDYNE Issues Correction on Financial Claims Announcement

CYBERDYNE Inc. has issued a correction to its previous announcement regarding the risk of irrecoverability or delayed collection of claims. The correction involves a change in the percentage of consolidated net assets affected by a loan to LeyLine, which has been adjusted from 0.01% to 0.64%. This correction may impact stakeholders’ perception of the company’s financial stability.

CYBERDYNE Faces Potential Loan Recovery Challenges with Former Subsidiary

CYBERDYNE Inc. has announced a potential risk regarding the irrecoverability or delayed collection of a loan to LeyLine GmbH, a former subsidiary. The company has recorded an allowance for doubtful accounts amounting to ¥252 million due to delays in repayment. CYBERDYNE plans to continue collection efforts and may consider legal actions to protect its receivables.

CYBERDYNE Reports Improved Profit Amid Revenue Decline

CYBERDYNE, INC. reported its consolidated financial results for the six months ending September 30, 2025, showing a decrease in revenue by 8.4% compared to the previous year. Despite the revenue drop, the company managed to achieve a profit before tax of 297 million yen, indicating a positive turnaround from the previous year’s loss. The company did not provide a forecast for the fiscal year ending March 31, 2026, due to uncertainties in the innovative market it operates in.

CYBERDYNE Selected for Ukraine Reconstruction Subsidy

CYBERDYNE has been selected for a subsidy under the Japanese government’s program to support Ukraine’s reconstruction. The company will establish a next-generation Cybernics treatment center in Ukraine, partnering with UNBROKEN in Lviv, to aid in the social reintegration of war-affected individuals and restore medical infrastructure.